Sector ratings Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-05-11 EDT			5-day change	1st Jan Change
300.00 ^DKK	+3.34%		+6.03%	-7.76%

09:53am	Cellular Intelligence Acquires Global Rights to Parkinson's Cell Therapy Program from Novo Nordisk	MT
09:37am	Cellular intelligence enters agreement with Novo Nordisk to advance clinical-stage Parkinson's cell therapy	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
NOVO NORDISK A/S	203B		A
ELI LILLY AND COMPANY	846B		A
JOHNSON & JOHNSON	533B		BBB
ABBVIE INC.	356B	-	AA	-	-
ROCHE HOLDING AG	324B		AA
ASTRAZENECA PLC	282B		A
NOVARTIS AG	278B		AAA
MERCK & CO., INC.	275B		A
AMGEN INC.	179B		A
GILEAD SCIENCES, INC.	163B		AA
PFIZER INC.	146B		A
BRISTOL-MYERS SQUIBB COMPANY	115B		A
VERTEX PHARMACEUTICALS INCORPORATED	109B		AA
SANOFI	103B		AA
GSK PLC	100B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	83.01B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.58B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.53B		AA
BAYER AG	42.76B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	41.6B		-
Average	214.18B		AA
Weighted average by Cap.			AA